Mylan Pharmaceuticals Inc. recalls Loxapine Capsules, USP 25 mg, Rx Only, 100-count bottles, NDC 0378-7025-01
Recalled May 30, 2018 · FDA recall D-0824-2018 · Mylan Pharmaceuticals
Hazard
CGMP Deviations · FDA Class II
Units
8,679 bottles
Sold at
Product was distributed throughout the United States, including Puerto Rico.
Description
CGMP Deviations
Product
Loxapine Capsules, USP 25 mg, Rx Only, 100-count bottles, NDC 0378-7025-01
Manufacturer(s)
Mylan Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →